Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia

Priscilla Wander, Laurence C. Cheung, Sandra S. Pinhanҫos, Luke Jones, Mark Kerstjens, Susan T.C.J.M. Arentsen-Peters, Sajla Singh, Grace Alyssa Chua, Patricia Garrido Castro, Pauline Schneider, M. Emmy M. Dolman, Bianca Koopmans, Jan J. Molenaar, Rob Pieters, C. Michel Zwaan, Rishi S. Kotecha, Ronald W. Stam

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)2898-2902
Number of pages5
Issue number11
Publication statusPublished - 1 Nov 2020


  • Animals
  • Antimetabolites, Antineoplastic/pharmacology
  • Antineoplastic Combined Chemotherapy Protocols/adverse effects
  • Deoxycytidine/analogs & derivatives
  • Disease Management
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Gene Rearrangement
  • Genetic Predisposition to Disease
  • Humans
  • Infant
  • Myeloid-Lymphoid Leukemia Protein/genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy
  • Gemcitabine

Cite this